Clinical and Ultrastructural Studies of Rombergʼs Hemifacial Atrophy
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 85 (5) , 669-674
- https://doi.org/10.1097/00006534-199005000-00001
Abstract
Romberg's disease is an uncommon and poorly understood condition manifested by progressive hemifacial atrophy of skin, soft tissue, and bone. In order to better define the natural history and anatomic variation of this disorder, we evaluated 41 patients by history, physical examination, and facial radiographs. Light microscopic studies were performed on tissue from 19 patients, and ultrastructural analysis was performed on specimens from 6 patients. The average age at inception of the disease was 8.8 years. Atrophy, within one or more trigeminal nerve dermatomes, progressed at a variable rate (mean period of active tissue dissolution = 8.9 ± 6 years). In 26 patients with skeletal involvement, the mean age of onset was 5.4 years, versus 15.4 years for 15 patients without skeletal involvement, a statistically significant difference (p < 0.01). However, there was no correlation between the severity of soft-tissue deformity and the age of onset. Electron microscopy demonstrated lymphocytic infiltrates in neurovascular bundles and abnormalities of vascular endothelium and basement membranes. We hypothesize that the pathogenesis of Romberg's disease involves chronic cell-mediated vascular injury and incomplete endothelial regeneration along branches of the trigeminal nerve (lymphocytic neurovasculitis).This publication has 9 references indexed in Scilit:
- Enhanced Angiogenic Capability of Monocyte-Enriched Mononuclear Cell Suspensions from Patients with Systemic SclerodermaJournal of Investigative Dermatology, 1986
- Juvenile linear scleroderma associated with serologic abnormalitiesArchives of Dermatology, 1985
- High titers of antibodies to single-stranded DNA in linear sclerodermaArchives of Dermatology, 1985
- Lowered Angiogeneic Capability of Peripheral Blood Lymphocytes in Progressive Systemic Sclerosis (Scleroderma)Journal of Investigative Dermatology, 1984
- Interleukin 1, a potential regulator of fibroblast proliferation.The Journal of Immunology, 1982
- Microvascular injury in lymphomatoid granulomatosis involving the skin. An ultrastructural studyArchives of Dermatology, 1981
- Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production.Journal of Clinical Investigation, 1980
- HUMAN MONOCYTE STIMULATION OF FIBROBLAST GROWTH BY A SOLUBLE MEDIATOR(S)1980
- Ultrastructure of cutaneous cellular infiltrates in sclerodermaArchives of Dermatology, 1977